Insmed (INSM) Free Cash Flow (2010 - 2026)

Insmed's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$226.2 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 16.88% year-over-year to -$226.2 million; the TTM figure through Mar 2026 stood at -$921.6 million (down 16.77% YoY), while the FY2025 annual figure was -$967.6 million, down 37.09% from the prior year.
• Free Cash Flow was -$226.2 million for Q1 2026 at Insmed, up from -$264.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$90.4 million in Q3 2022 to a low of -$272.2 million in Q1 2025.
• Historically, Free Cash Flow has averaged -$168.2 million across 5 years, with a median of -$149.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow gained 17.46% in 2022, then sank 61.14% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$107.8 million in 2022, then decreased by 23.3% to -$133.0 million in 2023, then tumbled by 52.48% to -$202.8 million in 2024, then tumbled by 30.3% to -$264.2 million in 2025, then climbed by 14.37% to -$226.2 million in 2026.
• The last three Free Cash Flow figures came in at -$226.2 million (Q1 2026), -$264.2 million (Q4 2025), and -$222.2 million (Q3 2025), per Business Quant data.